fluorometholone 1 MG/ML / sulfacetamide sodium 100 MG/ML Ophthalmic Suspension
- RxCUI
- 1000556
- RxNorm name
- fluorometholone 1 MG/ML / sulfacetamide sodium 100 MG/ML Ophthalmic Suspension
- Term type
- SCD
- Status
- Active
- Updated
- 2026-06-13 07:04:37
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092010
- Active start
- 092010
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
Ingredient, Strength, Base table| Ingredient | Strength | Base | Basis of strength |
|---|
| sulfacetamide sodium | 100 MG / 1 ML | sulfacetamide | sulfacetamide sodium |
| fluorometholone | 1 MG / 1 ML | fluorometholone | fluorometholone |
Derived Ingredient Concepts#
RxNav Current And Historical NDCs#
NDC11, Source, Active table| NDC11 | Source | Active |
|---|
| 00023442205 | rxnav_historical_indirect | |
| 00023442210 | rxnav_historical_indirect | |
| 00247089605 | rxnav_historical_indirect | |
| 00247089710 | rxnav_historical_indirect | |
| 11980042205 | rxnav_historical_indirect | |
| 11980042210 | rxnav_historical_indirect | |
| 53002085771 | rxnav_historical_indirect | |
| 53002085772 | rxnav_historical_indirect | |
| 58016609601 | rxnav_historical_indirect | |
DailyMed RxNorm Mappings#
Set ID, RxNorm string, TTY table| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|
| 9d71d7fd-2b25-4163-922f-018ed8c5171f | fluorometholone 1 MG/ML / sulfacetamide sodium 100 MG/ML Ophthalmic Suspension | SCD | 1 | FML-S ® (fluorometholone and sulfacetamide sodium ophthalmic suspension, USP) 0.1%/10% | 20070220 |
| 9d71d7fd-2b25-4163-922f-018ed8c5171f | fluorometholone 0.1 % / sulfacetamide sodium 10 % Ophthalmic Suspension | SY | 1 | FML-S ® (fluorometholone and sulfacetamide sodium ophthalmic suspension, USP) 0.1%/10% | 20070220 |
| 9d71d7fd-2b25-4163-922f-018ed8c5171f | fluorometholone 0.1 % / sulfacetamide sodium 10 % Ophthalmic Suspension | PSN | 1 | FML-S ® (fluorometholone and sulfacetamide sodium ophthalmic suspension, USP) 0.1%/10% | 20070220 |
DailyMed Labels#
Set ID, Title, Manufacturer table| Set ID | Title | Manufacturer | Effective |
|---|
| 9d71d7fd-2b25-4163-922f-018ed8c5171f | FML-S ® (fluorometholone and sulfacetamide sodium ophthalmic suspension, USP) 0.1%/10% | Allergan, Inc. | 20070220 |
Drug Classes#
Source, Class ID, Class table| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|
| ATC | D10AF | Antiinfectives for treatment of acne | ATC1-4 | | sulfacetamide |
| ATC | C05AA | Corticosteroids | ATC1-4 | | fluorometholone |
| ATC | D10AA | Corticosteroids, combinations for treatment of acne | ATC1-4 | | fluorometholone |
| ATC | D07AB | Corticosteroids, moderately potent (group II) | ATC1-4 | | fluorometholone |
| ATC | D07XB | Corticosteroids, moderately potent, other combinations | ATC1-4 | | fluorometholone |
| ATC | S01BA | Corticosteroids, plain | ATC1-4 | | fluorometholone |
| ATC | S01CB | Corticosteroids/antiinfectives/mydriatics in combination | ATC1-4 | | fluorometholone |
| ATC | S01AB | Sulfonamides | ATC1-4 | | sulfacetamide |
| FDASPL | D013449 | Sulfonamides | CHEM | has_chemical_structure | sulfacetamide |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | fluorometholone |
| FDASPL | N0000175503 | Sulfonamide Antibacterial | EPC | has_epc | sulfacetamide |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | fluorometholone |
| MEDRT | D005469 | Fluorometholone | CHEM | has_ingredient | fluorometholone |
| MEDRT | D013409 | Sulfacetamide | CHEM | has_ingredient | sulfacetamide |
| MEDRT | D013409 | Sulfacetamide | CHEM | has_ingredient | sulfacetamide sodium |
| MEDRT | D003231 | Conjunctivitis | DISEASE | may_treat | fluorometholone |
| MEDRT | D003236 | Conjunctivitis, Viral | DISEASE | ci_with | fluorometholone |
| MEDRT | D003316 | Corneal Diseases | DISEASE | ci_with | fluorometholone |
| MEDRT | D003320 | Corneal Ulcer | DISEASE | may_treat | sulfacetamide sodium |
| MEDRT | D003320 | Corneal Ulcer | DISEASE | may_treat | sulfacetamide |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | sulfacetamide |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | sulfacetamide sodium |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | sulfacetamide sodium |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | sulfacetamide |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | fluorometholone |
| MEDRT | D004427 | Ear Diseases | DISEASE | may_treat | sulfacetamide |
| MEDRT | D004427 | Ear Diseases | DISEASE | may_treat | sulfacetamide sodium |
| MEDRT | D015821 | Eye Infections, Fungal | DISEASE | ci_with | fluorometholone |
| MEDRT | D007231 | Infant, Newborn | DISEASE | ci_with | sulfacetamide |
| MEDRT | D007231 | Infant, Newborn | DISEASE | ci_with | sulfacetamide sodium |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | fluorometholone |
| MEDRT | D007634 | Keratitis | DISEASE | may_treat | fluorometholone |
| MEDRT | D017192 | Skin Diseases, Bacterial | DISEASE | may_treat | sulfacetamide sodium |
| MEDRT | D017192 | Skin Diseases, Bacterial | DISEASE | may_treat | sulfacetamide |
| MEDRT | D014141 | Trachoma | DISEASE | may_treat | sulfacetamide sodium |
| MEDRT | D014141 | Trachoma | DISEASE | may_treat | sulfacetamide |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | fluorometholone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | fluorometholone |
| MEDRT | N0000009946 | Para-Aminobenzoic Acid Inhibitors | MOA | has_moa | sulfacetamide sodium |
| MEDRT | N0000009946 | Para-Aminobenzoic Acid Inhibitors | MOA | has_moa | sulfacetamide |
| MEDRT | N0000008344 | Cellular Growth Phase Arrest | PE | has_pe | sulfacetamide |
| MEDRT | N0000008344 | Cellular Growth Phase Arrest | PE | has_pe | sulfacetamide sodium |
| MEDRT | N0000008347 | Cellular Synthetic Activity Alteration | PE | has_pe | sulfacetamide |
| MEDRT | N0000008347 | Cellular Synthetic Activity Alteration | PE | has_pe | sulfacetamide sodium |
| MEDRT | N0000009935 | Decreased Folic Acid Modification | PE | has_pe | sulfacetamide |
| MEDRT | N0000009935 | Decreased Folic Acid Modification | PE | has_pe | sulfacetamide sodium |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | fluorometholone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | fluorometholone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | fluorometholone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | fluorometholone |
Properties#
Category, Property, Value table| Category | Property | Value |
|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | TTY | SCD |
| CODES | MMSL_CODE | CD3245 |
| CODES | RxCUI | 1000556 |
| CODES | SNOMEDCT | 377424007 |
| CODES | VUID | 4009250 |
| NAMES | Prescribable Synonym | fluorometholone 0.1 % / sulfacetamide sodium 10 % Ophthalmic Suspension |
| NAMES | RXNAV_STR | fluorometholone 1 MG/ML / sulfacetamide sodium 100 MG/ML Ophthalmic Suspension |
| NAMES | RxNorm Name | fluorometholone 1 MG/ML / sulfacetamide sodium 100 MG/ML Ophthalmic Suspension |
| NAMES | RxNorm Synonym | fluorometholone 0.1 % / sulfacetamide sodium 10 % Ophthalmic Suspension |
| SOURCES | Source | US Edition of SNOMED_CT |